Mark P. Schoenberg, MD

Baltimore, Maryland 21287-2101

0 studies enrolling now · 1 studies all time

What they study most

Urinary Tract Urothelial Carcinoma

Studies at this site

• Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma — Completed